Evidence shows that combined inhibition of p110δ and mitogen-extracellular activated protein kinase (MEK) has synergistic cytotoxicity in human acute myeloid leukemia progenitors [38]. The gene discussed is PIK3CD; the disease is acute myeloid leukemia.